Serum 1,5-anhydroglucitol is associated with diabetic retinopathy in Type 2 diabetes

Diabetic Medicine

Volumn 29, Issue 9, 2012, Pages 1184-1190

  Kim, W J ^a   Park, C Y ^a   Park, S E ^a   Rhee, E J ^a   Lee, W Y ^a   Oh, K W ^a   Park, S W ^a   Kim, S W ^a   Park, H S ^a   Kim, Y J ^b   Song, S J ^a   Ahn, H Y ^c  

^a School of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Dongguk University   (South Korea)

Author keywords

1,5 anhydroglucitol; Albuminuria; Retinopathy; Type 2 diabetes mellitus

Indexed keywords

1,5 ANHYDROSORBITOL; ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALBUMINURIA; ARTICLE; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERTENSION; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SMOKING; SYSTOLIC BLOOD PRESSURE;

ALBUMINURIA; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DEOXYGLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; REPUBLIC OF KOREA; RISK FACTORS;

EID: 84865113079     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2012.03613.x     Document Type: Article

References (25)

1. Monnier L, Colette C. Glycemic variability: should we and can we prevent it? Diabetes Care 2008; 31: 150S-154S.
2. Ceriello A, Hanefeld M, Leiter L, Monnier L, Moses A, Owens D et al. Postprandial glucose regulation and diabetic complications. Arch Intern Med 2004; 164: 2090-2095.
3. Bonora E, Corrao G, Bagnardi V, Ceriello A, Comaschi M, Montanari P et al. Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus. Diabetologia 2006; 49: 846-854.
4. Borg R, Kuenen JC, Carstensen B, Zheng H, Nathan DM, Heine RJ et al. Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA1c: the A1C-Derived Average Glucose (ADAG) study. Diabetologia 2010; 53: 1608-1611.
5. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006; 295: 1681-1687.
6. Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008; 57: 1349-1354.
7. Zoppini G, Verlato G, Targher G, Casati S, Gusson E, Biasi V et al. Is fasting glucose variability a risk factor for retinopathy in people with type 2 diabetes? Nutr Metab Cardiovasc Dis 2009; 19: 334-339.
8. Gimeno-Orna JA, Castro-Alonso FJ, Boned-Juliani B, Lou-Arnal LM. Fasting plasma glucose variability as a risk factor of retinopathy in Type 2 diabetic patients. J Diabetes Complications 2003; 17: 78-81.
9. Won JC, Park CY, Park HS, Kim JH, Choi ES, Rhee EJ et al. 1, 5-Anhydroglucitol reflects postprandial hyperglycemia and a decreased insulinogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes. Diabetes Res Clin Pract 2009; 84: 51-57.
10. Kishimoto M, Yamasaki Y, Kubota M, Arai K, Morishima T, Kawamori R et al. 1, 5-Anhydro-d-glucitol evaluates daily glycemic excursions in well-controlled NIDDM. Diabetes Care 1995; 18: 1156-1159.
11. Stettler C, Stahl M, Allemann S, Diem P, Schmidlin K, Zwahlen M et al. Association of 1, 5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients. Diabetes Care 2008; 31: 1534-1535.
12. Dungan KM, Buse JB, Largay J, Kelly MM, Button EA, Kato S et al. 1, 5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes Care 2006; 29: 1214-1219.
13. Grading diabetic retinopathy from stereoscopic color fundus photographs - an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991; 98: 786-806.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
15. 1c- need for additional markers of risk for diabetic microvascular complications. JAMA 2010; 303: 2291-2292.
16. Selvin E, Francis LM, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL et al. Nontraditional markers of glycemia: associations with microvascular conditions. Diabetes Care 2011; 34: 960-967.
17. Emoto M, Tabata T, Inoue T, Nishizawa Y, Morii H. Plasma 1, 5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus. Nephron 1992; 61: 181-186.
18. Fujisawa T, Ikegami H, Tsutsui T, Kawaguchi Y, Ueda H, Shintani M et al. Renal tubular function affects glycosuria-related urinary excretion of 1, 5-anhydroglucitol. Diabetes Care 1999; 22: 863-864.
19. Buse JB, Freeman JL, Edelman SV, Jovanovic L, McGill JB. Serum 1, 5-anhydroglucitol (GlycoMark): a short-term glycemic marker. Diabetes Technol Ther 2003; 5: 355-363.
20. Beulens JWJ, Patel A, Vingerling JR, Cruickshank JK, Hughes AD, Stanton A et al. Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with Type 2 diabetes mellitus: a randomized controlled trial. Diabetologia 2009; 52: 2027-2036.
21. UK Prospective Diabetes Study (UKPDS) Group. Risks of progression of retinopathy and vision loss related to tight blood pressure control in Type 2 diabetes mellitus. Arch Ophthalmol 2004; 122: 1631-1640.
22. Kowluru RA, Zhong Q, Kanwar M. Metabolic memory and diabetic retinopathy: role of inflammatory mediators in retinal pericytes. Exp Eye Res 2010; 90: 617-623.
23. Li W, Liu X, Yanoff M, Cohen S, Ye X. Cultured retinal capillary pericytes die by apoptosis after an abrupt fluctuation from high to low glucose levels: a comparative study with retinal capillary endothelial cells. Diabetologia 1996; 39: 537-547.
24. Yamanouchi T, Minoda S, Yabuuchi M, Akanuma Y, Akanuma H, Miyashita H et al. Plasma 1, 5-anhydro-d-glucitol as new clinical marker of glycemic control in NIDDM patients. Diabetes 1989; 38: 723-729.
25. Yamanouchi T, Ogata N, Tagaya T, Kawasaki T, Sekino N, Funato H et al. Clinical usefulness of serum 1, 5-anhydroglucitol in monitoring glycaemic control. Lancet 1996; 347: 1514-1518.